Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Ifrah

Showing results (91-100 of 169) with videos related to

Pageof 17
Sort By:
Hematological Oncology|December 9, 2017
Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemiaFrancis Lacombe, Lydia Campos, Kaoutar Allou, et al.
Haematologica|September 3, 2016
International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemiaNicola Gökbuget, Hervè Dombret, Jose-Maria Ribera, et al.
Haematologica|October 3, 2009
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemiaOlivier Kosmider, Véronique Gelsi-Boyer, Marion Ciudad, et al.
American Journal of Hematology|August 23, 2012
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS studyRomain Guièze, Pascale Cornillet-Lefebvre, Bruno Lioure, et al.
British Journal of Haematology|December 15, 2005
A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des MyélodysplasiesDidier Bouscary, Laurence Legros, Micheline Tulliez, et al.
Haematologica|July 17, 2010
Mutations in TP53 are exclusively associated with del(17p) in multiple myelomaLaurence Lodé, Marion Eveillard, Valérie Trichet, et al.
Oncotarget|February 22, 2018
SNP-array lesions in core binding factor acute myeloid leukemiaNicolas Duployez, Elise Boudry-Labis, Christophe Roumier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experienceCharikleia Kelaidi, Sylvie Chevret, Stéphane De Botton, et al.
Haematologica|September 24, 2009
Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemiaSébastien Maury, Françoise Huguet, Thibaut Leguay, et al.
Molecular Cancer|July 10, 2023
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2Estelle Balducci, Thomas Steimlé, Charlotte Smith, et al.
Pageof 17

Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Hematological Oncology|December 9, 2017
Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemiaFrancis Lacombe, Lydia Campos, Kaoutar Allou, et al.
Haematologica|September 3, 2016
International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemiaNicola Gökbuget, Hervè Dombret, Jose-Maria Ribera, et al.
Haematologica|October 3, 2009
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemiaOlivier Kosmider, Véronique Gelsi-Boyer, Marion Ciudad, et al.
American Journal of Hematology|August 23, 2012
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS studyRomain Guièze, Pascale Cornillet-Lefebvre, Bruno Lioure, et al.
British Journal of Haematology|December 15, 2005
A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des MyélodysplasiesDidier Bouscary, Laurence Legros, Micheline Tulliez, et al.
Haematologica|July 17, 2010
Mutations in TP53 are exclusively associated with del(17p) in multiple myelomaLaurence Lodé, Marion Eveillard, Valérie Trichet, et al.
Oncotarget|February 22, 2018
SNP-array lesions in core binding factor acute myeloid leukemiaNicolas Duployez, Elise Boudry-Labis, Christophe Roumier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experienceCharikleia Kelaidi, Sylvie Chevret, Stéphane De Botton, et al.
Haematologica|September 24, 2009
Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemiaSébastien Maury, Françoise Huguet, Thibaut Leguay, et al.
Molecular Cancer|July 10, 2023
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2Estelle Balducci, Thomas Steimlé, Charlotte Smith, et al.
Pageof 17